Medicinal Uses of Macromycetes Among Populations in Ecological Zone II of Togo
Abstract
Objective : To comprehensively document the medicinal uses of macromycetes among the riparian populations of Ecological Zone II of Togo, with a view to their sustainable management.
Material And Methods : The mushrooms were collected from the vegetation formations of the ecological zone and then presented to the local riparian population. The medicinal mushrooms were identified by the local population, who specified the type of disease treated, the mode of use, and the dosage. For species identification, macroscopic and microscopic studies were conducted on each species, allowing for the determination of their names.
For statistical analyses, the R software was used for Correspondence Factor Analysis, and the Canoco software was used for PCA analyses.
Résultats : The bivariate analysis shows that the use of medicinal mushrooms is not linked to ethnicity (Chi-2 = 96.105; p = 0.106). The Correspondence Analysis (CA) reveals three groups of diseases : G1 (mild conditions) treated by the Tem and Kabyè, G2 (more severe pathologies) treated by the Bassar, and G3 (serious diseases such as cancer and diabetes) cited by the Nawdba and Moba. The Dim1 (42.7%) and Dim2 (25.8%) axes together explain 68.5% of the variance, highlighting a severity gradient of diseases. The PCA analysis shows that different populations exploit various fungal species to treat different diseases, with a single species capable of addressing multiple ailments. Six groups are distinguished based on their medicinal properties: G1 (Termitomyces schimperi, Volvariella earlei) linked to immunity and cancer, G2 (Pleurotus sp.) associated with diabetes, G3 (Polyporus squarrosulus) with asthma, G4 (Ganoderma colossus) with hormonal disorders, G5 (Daldinia eschscholzii) with ulcers, and G6 (Phellinus sp.) with cardiovascular diseases. Ganoderma lucidum, positioned at the center, appears to have a broad therapeutic spectrum.
Conclusion : The use of medicinal mushrooms transcends ethnic boundaries and adapts based on transmitted knowledge and encountered pathologies. PCA has identified the species with the highest therapeutic potential according to medical indications.
Keywords : Medicinal mushrooms, Ethnopharmacology, Principal Component Analysis, Ecological Zone II, Togo
Keywords:
Medicinal mushrooms, Ethnopharmacology, Principal Component Analysis, Ecological Zone II, TogoDOI
https://doi.org/10.22270/jddt.v15i4.7075References
1- Kwame, A. Integrating traditional medicine and healing into the Ghanaian mainstream health system : voices from within. Qualitative Health Research, 2021;31(10):1847-1860. https://doi.org/10.1177/10497323211008849 PMid:33980093 PMCid:PMC8446885
2- Guissou, K. M., Sanon, E., Sankara, P. H., & Guinko, S. La mycothérapie au Burkina Faso : État des lieux et perspectives. Journal of Applied Biosciences, 2014;79:6896-6908. https://doi.org/10.4314/jab.v79i0.14
3- Hama, O., Ibrahim, D., Baragé, M., Alhou, B., Daniëls, P. P., & Infante, F. Utilisations de quelques espèces de Macromycètes dans la pharmacopée traditionnelle au Niger occidental (Afrique de l'Ouest). Journal of Applied Biosciences, 2012;57:4159-4167.
4- Oyetayo, O. V. Medicinal uses of mushrooms in Nigeria: towards full and sustainable exploitation. African Journal of Traditional, Complementary and Alternative Medicines, 2011;8(3). https://doi.org/10.4314/ajtcam.v8i3.65289 PMid:22468005 PMCid:PMC3252220
5- Kinge, T. R., Tabi, E. M., Mih, A. M., Enow, E. A., Njouonkou, L., & Nji, T. M. Ethnomycological studies of edible and medicinal mushrooms in the mount Cameroon region (Cameroon, Africa). International Journal of Medicinal Mushrooms, 2011;13(3). https://doi.org/10.1615/IntJMedMushr.v13.i3.100 PMid:22135882
6- Yian, G. C., Pitta, B. M. S., & Tiébré, M. S. Champignons sauvages comestibles et pharmacopée traditionnelle en zone forestière de la Côte d'Ivoire. IOSR Journal of Pharmacy and Biological Sciences, 2020;15:35-45. DOI : https://doi.org/10.9790/3008-1502023545
7- Diop, M., Niang-Diop, F., Dieng, S. D., Samb, A., Manga, G. E. D., Sané, A. P., ... & Diatta, E. A. Ethnobotanical study of medicinal plants for treatment of diabetes and hypertension used in communities near Fathala Forest, Senegal. Ethnobotany Research and Applications, 2022;23:1-15. https://doi.org/10.32859/era.23.7.1-15
8- Kamou, H., Nadjombe, P., Gbogbo, a. K., Yorou, s. N., Batawila, K., Akpagana, k., & Guelly, k. A. Les champignons ectomycorrhiziens consommés par les Bassar et les Kabyè, peuples riverains du Parc National Fazao-Malfakassa (PNFM) au Togo (Afrique de l'Ouest). Revue Marocaine des Sciences Agronomiques et Vétérinaires, 2017;5(2).
9- Kamou, H., Nadjambe, P., Guelly, K. A., Yorou, S. N., Maba, L. D., & Akpagana, K. Les champignons sauvages comestibles du Parc National Fazao-Malfakassa (PNFM) au Togo (Afrique de l'Ouest): Diversité et connaissances ethnomycologiques. Agronomie Africaine, 2015;27(1):37-46.
10- Ern, H. The vegetation of Togo. Structure, endangerment, conservation [In German]. Willdenowia, 1979;9:295-312.
11- Akodéwou, A., J. Oszwald, S. Akpavi, L. Gazull, K. Akpagana and V. Gond, Problem of invasive plants in Southern Togo (West Africa): Contribution of systemic landscape analysis and remote sensing [In French]. Biotechnol. Agron. Soc. Environ., 2019;22:88-103. https://doi.org/10.25518/1780-4507.17750
12- Atato, A., K. Wala, M. Dourma, R. Bellefontaine, Y.A. Woegan, K. Batawila and K. Akpagana, Lianas of Togo bearing edible fruit [In French]. Fruits, 2012;67:353-368. https://doi.org/10.1051/fruits/2012030
13- Strullu-Derrien, C., M.A. Selosse, P. Kenrick and F.M. Martin, The origin and evolution of mycorrhizal symbioses: From palaeomycology to phylogenomics. New Phytol., 2018;220:1012-1030. https://doi.org/10.1111/nph.15076 PMid:29573278
14- Watling, R., New combinations in Boletaceae and Gomphidiaceae (Boletales). Edinburgh J. Bot., 2004;61:41-47. https://doi.org/10.1017/S0960428604000058
15- Ebika, S.T.N., J.E.I. Codjia, N.S. Yorou and Attibayeba, Wild edible fungi and indigenous knowledge of Mbènzèlè and Ngombe populations in the Republic of Congo [In French]. J. Appl. Biosci., 2018;126:12675-12685. https://doi.org/10.4314/jab.v126i1.5
16- Maba, D.L., A.K. Guelly, N.S. Yorou and R. Agerer, Diversity of Lactifluus (Basidiomycota, Russulales) in West Africa: 5 new species described and some considerations regarding their distribution and ecology. Mycosphere, 2015;6:737-759. https://doi.org/10.5943/mycosphere/6/6/9
17- Meidl, P., B. Furneaux, K.I. Tchan, K. Kluting and M. Ryberg et al., Soil fungal communities of ectomycorrhizal dominated woodlands across West Africa. MycoKeys, 2021;81:45-68. https://doi.org/10.3897/mycokeys.81.66249 PMid:34475800 PMCid:PMC8390883
18- Verbeken, A., Studies in tropical African Lactarius species. 4. Species described by P. Hennings and M. Beeli. Edinburgh J. Bot., 1996;53:49-79. https://doi.org/10.1017/S0960428600002729
19- Yorou, S.N., A. de Kesel, B. Sinsin and J.T.C. Codjia, Diversity and productivity of edible mushrooms in the Wari-Maro classified forest (Benin, West Africa) [In French]. Syst. Geogr. Plants, 2001;71:613-625. https://doi.org/10.2307/3668706
20- De Kesel, A., J.T.C. Codjia and S.N. Yorou, Guide to Edible Mushrooms of Benin [In French]. National Botanical Garden of Belgium, Meise, Belgium, ISBN: 9991995323, 2002 ;274.
21- Johnson Afolabi, F., Babafemi Babaniyi, R., Obagunwa, M., Onile, F. O., Ajagun, E. J., Oyedele, O. J., & Adedayo Fasiku, S. Ethnomycology of Pleurotus tuber-regium and its use in food, medicine and bioremediation. Botanica Lithuanica, 2024;30(4). https://doi.org/10.35513/Botlit.2024.4.7
22- Ganesh Saravanan, K., Thiribhuvanamala, G., Praveen, T., Mahalakshmi, P., Angappan, K., Revathy, N., ... & Jayakanthan, M. Harnessing nature's treasure of bioactive compounds from ethnomedicinal Macromycos Lentinus squarrosulus Mont. Plant Science Today, 2024;11:5903. https://doi.org/10.14719/pst.5903
23- Tarun Verma, Raman Verma, Rahul Thawait, Aditya Kumar, Suchita Wamankar, Rajesh Kumar Nema , Ganoderma Lucidum: A Comprehensive Review of its Health Benefits and Therapeutic Potential. International Journal of Advanced Multidisciplinary Research and Studies. 2025;4(6):2024. https://doi.org/10.62225/2583049X.2024.4.6.3593
24- Das, A., Chen, C. M., Mu, S. C., Yang, S. H., Ju, Y. M., & Li, S. C. Medicinal components in edible mushrooms on diabetes mellitus treatment. Pharmaceutics, 202214(2):436. https://doi.org/10.3390/pharmaceutics14020436 PMid:35214168 PMCid:PMC8875793
25- Wasser, S. P. Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities: a review. International journal of medicinal mushrooms, 2017;19(4). https://doi.org/10.1615/IntJMedMushrooms.v19.i4.10 PMid:28605319
26- Lindequist, U., Niedermeyer, T. H., & Jülich, W. D. The pharmacological potential of mushrooms. Evidence‐Based Complementary and Alternative Medicine, 2005;2(3):285-299. https://doi.org/10.1093/ecam/neh107 PMid:16136207 PMCid:PMC1193547
27- Wang, H., Ma, J. X., Zhou, M., Si, J., & Cui, B. K. Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang. Frontiers in Microbiology, 2022;13:965934. https://doi.org/10.3389/fmicb.2022.965934 PMid:35992671 PMCid:PMC9382022
28- Karunarathna, S. C., Patabendige, N. M., Lu, W., Asad, S., & Hapuarachchi, K. K. An In-Depth Study of Phytopathogenic Ganoderma: Pathogenicity, Advanced Detection Techniques, Control Strategies, and Sustainable Management. Journal of Fungi, 2024;10(6):414. https://doi.org/10.3390/jof10060414 PMid:38921400 PMCid:PMC11204718
Published



How to Cite
Issue
Section
Copyright (c) 2025 Essossimna MAGAMANA, Pondikpa NADJOMBE, Hodabalo KAMOU, Mamatchi MELILA, Kokou Elohanna AGOSSOU, Marra DOURMA, Kpérkouma WALA, Kudzo Atsu GUELLY

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).